Most patients with coronary artery disease (CAD) and chronic stable angina will obtain complete relief of symptoms with percutaneous coronary intervention (PCI). However, some chronic angina patients ...

Depression can occur in approximately 1 in 5 patients who have chronic stable angina. After diagnosis of chronic stable angina, depression can occur in approximately 1 in 5 patients, according to a ...

Background: Chronic angina carries an economicburden because of symptom management, the riskof major cardiovascular events, and lost productivity.The level of these costs has not been ...

Complete revascularization with PCI results in better health status for patients with multivessel, stable CAD than either incomplete revascularization or a conservative strategy of guideline-directed ...

PHILADELPHIA -- The symptoms of stable angina can be eased by percutaneous coronary intervention (PCI) alone in the absence of antianginal medications, the randomized ORBITA-2 trial showed. Compared ...

Please provide your email address to receive an email when new articles are posted on . The study included data on 32,691 patients with stable CAD from the prospective, observational CLARIFY registry.

Researchers at the University of Illinois Chicago have received a $3.12 million National Institutes of Health grant to study whether acupuncture can alleviate chest pain caused by stable angina.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among stable outpatients with CAD, 21.2% reported ...

The results of TERISA, a randomized, double-blind trial in which the effect of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina was examined, were reported at the ACC ...

SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...

In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug, ...